Siris Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.15 M
- Company Age 33 Year, 11 Months
- Last Filing with ROC 31 Mar 2010
- Open Charges ₹ 3.20 M
About Siris Laboratories
Siris Laboratories Private Limited (SLPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 February 1991 and has a history of 33 years and 11 months. Its registered office is in A.P, Andhra Pradesh.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2010. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.15 M.
The company currently has active open charges totaling ₹3.20 M.
Subbaraju Gokaraju and Bangaramma Kalidindi serve as directors at the Company.
Company Details
- LocationA.P, Andhra Pradesh
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24110AP1991PTC012388
- Company No.
012388
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Feb 1991
- Date of AGM
30 Sep 2010
- Date of Balance Sheet
31 Mar 2010
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Siris Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subbaraju Gokaraju  | Director | 01-Apr-1997 | Current |
| Bangaramma Kalidindi | Director | 27-Feb-1991 | Current |
Financial Performance of Siris Laboratories.
Enhance accessibility to Siris Laboratories's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Siris Laboratories?
Unlock access to Siris Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Golden Royal Warehouses Private LimitedBangaramma Kalidindi is a mutual person
Charges (Loans)
₹3.20 M
₹0
Charges Breakdown by Lending Institutions
- Andhra Bank : 0.32 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Oct 1995 | Andhra Bank | ₹1.60 M | Open |
| 01 Oct 1993 | Andhra Bank | ₹1.60 M | Open |
How Many Employees Work at Siris Laboratories?
Unlock and access historical data on people associated with Siris Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Siris Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Siris Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.